Additionally, many tumor antigens are restricted to specific HLA types (class I restricted cytotoxic T cell or class II restricted helper T cell epitopes), for example HER-2, IL13Ra2, MAGE-1, and survivin. This evidence concerns the gene ERBB2 and neoplasm.